Double Blind,Randomized, Placebo Controlled Trial of Adjunctive Tianeptine in the Treatment of Bipolar Depression
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 07 Oct 2013
At a glance
- Drugs Tianeptine (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- 07 Oct 2013 Planned end date changed from 1 Sep 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 07 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Apr 2009 New trial record